Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $488.0 million.

  • GE HealthCare Technologies' Net Cash Flow rose 18079.47% to $488.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 23269.23%. This contributed to the annual value of $1.6 billion for FY2025, which is 23269.23% up from last year.
  • According to the latest figures from Q4 2025, GE HealthCare Technologies' Net Cash Flow is $488.0 million, which was up 18079.47% from $280.0 million recorded in Q3 2025.
  • GE HealthCare Technologies' 5-year Net Cash Flow high stood at $1.5 billion for Q3 2024, and its period low was -$604.0 million during Q4 2024.
  • Moreover, its 4-year median value for Net Cash Flow was $70.0 million (2023), whereas its average is $250.2 million.
  • Examining YoY changes over the last 5 years, GE HealthCare Technologies' Net Cash Flow showed a top increase of 5070000.0% in 2023 and a maximum decrease of 115000.0% in 2023.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Net Cash Flow stood at $931.0 million in 2022, then crashed by 93.34% to $62.0 million in 2023, then plummeted by 1074.19% to -$604.0 million in 2024, then soared by 180.79% to $488.0 million in 2025.
  • Its Net Cash Flow stands at $488.0 million for Q4 2025, versus $280.0 million for Q3 2025 and $1.2 billion for Q2 2025.